| Ident. | Authors (with country if any) | Title |
|---|
| 000197 (2009) |
Anthony S. Russell [Canada] ; Wojtek P. Olszynski [Canada] ; K. S. Davison [Canada] ; Cheryl Koehn [Canada] ; Boulos Haraoui [Canada] | Leveling the field in the treatment of rheumatoid arthritis with biologic therapies: equal access for equal efficacy |
| 000231 (2012) |
I. Colmegna [Canada] ; B R Ohata [Canada] ; H A Menard [Canada] | Current Understanding of Rheumatoid Arthritis Therapy |
| 000232 (2014) |
Nigil Haroon [Canada] ; Debashish Danda [Inde] | ‘Bamboo spine’, a thing of the past? |
| 000366 (2013) |
J. E. Pope ; E. Rampakakis ; J. Sampalis ; O. Desjardins [Canada] | FRI0187 The effectiveness of abatacept in a large RA real world database including durability and changes in haq over time: Post DMARDs and post TNF |
| 000368 (2012) |
Vivian P. Bykerk [États-Unis, Canada] ; Andrew J K. Östör [Royaume-Uni] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Winfried Graninger [Autriche] ; William Bensen [Canada] ; Michael T. Nurmohamed [Pays-Bas] ; Andreas Krause [Allemagne] ; Corrado Bernasconi [Suisse] ; Andrea Stancati [Suisse] ; Jean Sibilia [France] | Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice |
| 000370 (2008) |
P. Emery [Royaume-Uni] ; E. Keystone [Canada] ; H P Tony [Allemagne] ; A. Cantagrel [France] ; R. Van Vollenhoven [Suède] ; A. Sanchez [Mexique] ; E. Alecock [Royaume-Uni] ; J. Lee [États-Unis] ; J. Kremer [États-Unis] | IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial |
| 000422 (2011) |
Carine Salliot [Canada] ; Axel Finckh [Suisse] ; Wanruchada Katchamart [Canada] ; Yan Lu [Canada] ; Ye Sun [Canada] ; Claire Bombardier [Canada] ; Edward Keystone [Canada] | Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis |
| 000529 (2013) |
J.-E. Gottenberg [France] ; C. Mpofu [Suisse] ; W. Bensen [Canada] ; A. Rubbert-Roth [Allemagne] ; F. Irazoque [Mexique] ; V. Martínez Taboada [Espagne] ; C. Chung [États-Unis] ; L. Hinsch-Gylvin [Suisse] ; C. Ferri [Italie] ; P. Emery [Royaume-Uni] | AB0541 Factors associated with selection of rituximab vs alternative TNF inhibitor (TNFI) following TNFI failure in patients with rheumatoid arthritis: Sub-analysis of switch-RA, a global, comparative effectiveness observational study |
| 000576 (2013) |
Marco Bigoni [Italie] ; Paola Sacerdote [Italie] ; Marco Turati [Italie] ; Silvia Franchi [Italie] ; Marta Gandolla [Italie] ; Diego Gaddi [Italie] ; Sarah Moretti [Italie] ; Daniele Munegato [Italie] ; Carlo A. Augusti [Italie] ; Elena Bresciani [Italie] ; Robert J. Omeljaniuk [Canada] ; Vittorio Locatelli [Italie] ; Antonio Torsello [Italie] | Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury |
| 000608 (2011) |
D E Furst [États-Unis] ; E C Keystone [Canada] ; J. Braun [Allemagne] ; F C Breedveld [Pays-Bas] ; G R Burmester [Italie] ; F. De Benedetti [Italie] ; T. Dörner [Italie] ; P. Emery [Royaume-Uni] ; R. Fleischmann [États-Unis] ; A. Gibofsky [États-Unis] ; J R Kalden [Allemagne] ; A. Kavanaugh [États-Unis] ; B. Kirkham [Royaume-Uni] ; P. Mease [États-Unis] ; J. Sieper [États-Unis] ; N G Singer [États-Unis] ; J S Smolen [Autriche] ; P L C M. Van Riel [Pays-Bas] ; M H Weisman [États-Unis] ; K. Winthrop [États-Unis] | Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010 |
| 000618 (2013) |
R. Alten [Allemagne] ; J. Kaine [États-Unis] ; E. Keystone [Canada] ; P. Nash [Australie] ; I. Delaet ; K. Qi ; M. C. Genovese [États-Unis] | AB0567 Safety of SC abatacept in patients with ra: Update from pooled clinical trial data |
| 000646 (2013) |
D. Choquette [Canada] ; O. Thomas ; M. Arundine [Canada] | AB0523 Lower than expected levels of DMARD acquisition immediately pre and post biologic initiation in RA patients |
| 000649 (2012) |
D E Furst [États-Unis] ; E C Keystone [Canada] ; J. Braun [Allemagne] ; F C Breedveld [Pays-Bas] ; G R Burmester [Allemagne] ; F. De Benedetti [Italie] ; T. Dörner [Allemagne] ; P. Emery [Royaume-Uni] ; R. Fleischmann [États-Unis] ; A. Gibofsky [États-Unis] ; J R Kalden [Allemagne] ; A. Kavanaugh [États-Unis] ; B. Kirkham [Royaume-Uni] ; P. Mease [États-Unis] ; J. Sieper [Allemagne] ; N G Singer [États-Unis] ; J S Smolen [Autriche] ; P L C M. Van Riel [Pays-Bas] ; M H Weisman [États-Unis] ; K. Winthrop [États-Unis] | Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011 |
| 000653 (2013) |
Daniel E. Furst [États-Unis] ; Edward Clark Keystone [Canada] ; Alexander K. So [États-Unis, Canada, Allemagne, Pays-Bas, Italie, Royaume-Uni, Autriche] ; Jürgen Braun [Allemagne] ; Ferry C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Italie] ; Fabrizio De Benedetti [Allemagne] ; Thomas Dörner [Allemagne] ; Paul Emery [Royaume-Uni] ; Roy Fleischmann [États-Unis] ; Allan Gibofsky [États-Unis] ; J R Kalden [Allemagne] ; Arthur Kavanaugh [États-Unis] ; Bruce Kirkham [Royaume-Uni] ; Philip Mease [États-Unis] ; A. Rubbert-Roth [Allemagne] ; Joachim Sieper [Allemagne] ; Nora G. Singer [États-Unis] ; Josef S. Smolen [Autriche] ; Piet L C M. Van Riel [Pays-Bas] ; Michael H. Weisman [États-Unis] ; Kevin L. Winthrop [États-Unis] | Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012 |
| 000672 (2013) |
E. Rioux [Canada] ; I. Fortin [Canada] ; M.-J. Rioux [Canada] | AB0314 The survival rates of biologics treated patients at the centre de rhumatologie de l’est du quebec : description of the real world, canadian patient cohort. |
| 000725 (2013) |
J. A. Singh [États-Unis] ; G. Wells [Canada] ; R. Christensen [Danemark] ; E. Ghogomu [Canada] ; J. Macdonald [Canada] ; L. Maxwell [Canada] ; S. Tarp [Danemark] ; R. Buchbinder [Australie] ; P. Tugwell [Canada] | OP0071 Risk of Cancer, Serious Lung Infections and Death with Biologics: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials (RCTS) |
| 000729 (2016) |
Irina Voronov [Canada] | DEL1 – a new player in periodontal disease? |
| 000741 (2013) |
E. Keystone [Canada] ; S. B. Cohen [États-Unis] ; P. Emery [Royaume-Uni] ; J. M. Kremer [États-Unis] ; M. Dougados [France] ; J. E. Loveless ; C. Chung [États-Unis] ; P. Wong [États-Unis] ; P. B. Lehane [Royaume-Uni] ; H. Tyrrell [Royaume-Uni] | AB0526 Sustained efficacy responses and a consistent safety profile with rituximab repeat treatment over 5 years in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors in the reflex study |
| 000746 (2013) |
H. Nü Lein ; R. Alten [Allemagne] ; M. Galeazzi [Italie] ; H. M. Lorenz [Allemagne] ; D. Boumpas [Grèce] ; M. T. Nurmohamed [Pays-Bas] ; W. G. Bensen [Canada] ; G. R. Burmester [Allemagne] ; H. H. Peter [Allemagne] ; F. Rainer [Autriche] ; K. Pavelka [République tchèque] ; M. Chartier ; C. Poncet [France] ; C. Rauch [Allemagne] ; M. Le Bars [France] | AB0532 Effect of prior therapy on the efficacy and safety of abatacept: 6-month analysis of the action study |
| 000764 (2013) |
H. Nü Lein ; R. Alten [Allemagne] ; M. Galeazzi [Italie] ; H. M. Lorenz [Allemagne] ; D. Boumpas [Grèce] ; M. T. Nurmohamed [Pays-Bas] ; W. G. Bensen [Canada] ; G. R. Burmester [Allemagne] ; H. H. Peter [Allemagne] ; F. Rainer [Autriche] ; K. Pavelka [République tchèque] ; M. Chartier ; C. Poncet [France] ; C. Rauch [Allemagne] ; M. Le Bars [France] | AB0531 Real-world efficacy and safety of abatacept treatment for RA: 12-month interim analysis of the action study |
| 000828 (2013) |
E. Keystone [Canada] ; D. Weber [Canada] ; J. Xiong [Canada] ; Y. Sun [Canada] ; A. Grant [Canada] | FRI0226 Rituximab versus abatacept in rheumatoid arthritis patients with an inadequate response to prior biologic therapy: a retrospective single-center study |
